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ABSTRACT The differences between coarse and fine fibrin clots first reported by Ferry have been interpreted in terms of
nonspecific ionic strength effects for nearly 50 years and have fostered the notion that fibrin polymerization is largely
controlled by electrostatic forces. Here we report spectroscopic and electron microscopy studies carried out in the presence
of different salts that demonstrate that this long-held interpretation needs to be modified. In fact, the differences are due
entirely to the specific binding of Cl to fibrin fibers and not to generic ionic strength or electrostatic effects. Binding of Cl
opposes the lateral aggregation of protofibrils and results in thinner fibers that are also more curved than those grown in the
presence of inert anions such as F. The effect of Cl is pH dependent and increases at pH  8.0, whereas fibers grown in
the presence of F remain thick over the entire pH range from 6.5 to 9.0. From the pH dependence of the Cl effect it is
suggested that the anion exerts its role by increasing the pKa of a basic group ionizing around pH 9.2. The important role of
Cl in structuring the fibrin clot also clarifies the role played by the release of fibrinopeptide B, which leads to slightly thicker
fibers in the presence of Cl but actually reduces the size of the fibers in the presence of F. This effect becomes more
evident at high, close to physiological concentrations of fibrinogen. We conclude that Cl is a basic physiological modulator
of fibrin polymerization and acts to prevent the growth of thicker, stiffer, and straighter fibers by increasing the pKa of a basic
group. This discovery opens new possibilities for the design of molecules that can specifically modify the clot structure by
targeting the structural domains responsible for Cl binding to fibrin.
INTRODUCTION
Fibrinogen circulates in the plasma as a dimer of three
chains, (AB)2, covalently linked by disulfide bonds
(Doolittle, 1984; Binnie and Lord, 1993). After a vascular
lesion, fibrinogen is converted into fibrin monomers by the
fast form of thrombin, which cleaves the A chain and
releases fibrinopeptide A (Di Cera et al., 1997). The mono-
mers aggregate to form two stranded protofibrils promoting
a second highly specific cleavage by the fast form of throm-
bin at the B chain leading to the release of fibrinopeptide
B. These polymers are produced by specific interactions
between sites exposed by removal of the fibrinopeptides in
the central region of the molecule with complementary sites
at the ends of the molecule (Shainoff and Dardik, 1983;
Doolittle, 1984; Budzynski, 1986; Medved et al., 1993).
The protofibrils then aggregate to form thicker fibers (Hant-
gan and Hermans, 1979; Hantgan et al., 1980; Higgins et al.,
1983; Lewis et al., 1985). This leads to formation of a gel,
or fibrin clot, that anchors platelets to the site of injury and
initiates processes that stop the bleeding and promote
wound repair and healing.
Fibrin polymerization has been studied intensively over
the past 50 years because of the availability of large quan-
tities of fibrinogen for biochemical and biophysical charac-
terization. Ferry was the first to demonstrate that fibrin clots
formed at different ionic strengths are dramatically differ-
ent, with fibers becoming apparently thinner at high pH and
salt concentration (Ferry and Morrison, 1947). This seminal
observation has been reproduced by numerous other inves-
tigators (Shulman et al., 1953; Latallo et al., 1962; Nair et
al., 1986; Kaminski et al., 1991; Blomback et al., 1992;
Weisel and Nagaswami, 1992). Many other factors, includ-
ing Ca2 and other plasma proteins, exert a significant
influence on clot structure (Carr et al., 1985, 1986; Carr,
1988; Mihalyi, 1988; Weisel and Nagaswami, 1992; Blom-
back et al., 1994). Surprisingly, however, these previous
studies have not assessed the role of possible specific ion
binding interactions in fibrin polymerization. In Ferry’s
original experiments (Ferry and Morrison, 1947), and in
practically all subsequent studies (Shulman et al., 1953;
Latallo et al., 1962; Nair et al., 1986; Kaminski et al., 1991;
Blomback et al., 1992; Weisel and Nagaswami, 1992), the
ionic strength was changed with NaCl or other salts con-
taining Cl.
When the effect of different salts on clot structure was
first examined (Vindigni and Di Cera, 1996), it was found
that the concentration of Cl present in solution is the most
important variable that controls the size of fibrin fibers.
Clots grown at different ionic strength in the presence of
NaF, instead of NaCl, were found to retain the same struc-
ture in the ionic strength range from 100 to 500 mM. This
recent observation may have a profound impact on our
mechanistic understanding of fibrin polymerization and the
factors that regulate it. If specific binding interactions of
Cl determine the size and shape of fibrin fibers, the non-
specific electrostatic components invoked in previous anal-
yses become of marginal importance, and identification of a
specific structural domain responsible for Cl binding may
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provide new targets for drugs selectively designed to inter-
fere with fibrin polymerization.
The potential importance of the Cl effect in both phys-
iological and pharmacological terms, as well as the possi-
bility of unraveling aspects of the basic molecular mecha-
nism governing fibrin polymerization, have prompted a
more thorough characterization using a combination of
spectroscopic and electron microscopy measurements. This
yields a direct demonstration of the large and significant
effect of Cl on the fibrin clot and clarifies the role of
protons and fibrinopeptide B release in fibrin polymerization.
MATERIALS AND METHODS
Human fibrinogen was obtained from Enzyme Research (South Bend, IN)
and further purified using a Pharmacia PD-10 desalting column and a
gelatin-lysine affinity column (Bio-Rad, Hercules, CA). Ancrod snake
venom from Sigma Chemical Co. (St. Louis, MO) was dissolved in the
desired buffer and used at a concentration of 0.15 IU/ml equivalent in terms
of clotting activity to 4 nM thrombin. The activity of ancrod pertaining to
the exclusive release of fibrinopeptide A was checked directly by high-
pressure liquid chromatography analysis of the release of fibrinopeptides
(Vindigni and Di Cera, 1996). Under all conditions, thrombin was found to
release both fibrinopeptides A and B, whereas ancrod released only fibri-
nopeptide A. Measurements of turbidity over the pH range 6.5–9.0 were
carried out at 25°C under conditions of 10 mM 2-[N-Cyclohexylamino]eth-
anesulfonic acid (CHES), 5 mM Tris, 5 mM bisTris, 0.1% polyethylene
glycol (PEG), 1 mM EDTA by monitoring the increase in absorbance of
the sample as a function of time at 350 nm. The triple buffer ensured
buffering over the entire pH range with minimal perturbations in the ionic
strength of the solution (Ellis and Morrison, 1982). The concentration of
various anions, used as Na salts, was changed under all solution condi-
tions at an ionic strength of 200 mM kept constant with NaF.
The wavelength dependence of the turbidity of a fibrin gel was used to
calculate the average mass-length ratio of fibrin fibers (Carr and Hermans,
1978; Hantgan and Hermans, 1979). Spectra were recorded in the wave-
length range from 350 to 700 nm. The turbidity  defined as the absorbance
times ln10 is a measure of the intensity decrease of transmitted light due to
scattering. For rod-like particles with a diameter that is small compared
with the wavelength ,  should vary as 3 and should go to zero as 3
 (Casassa, 1955). The mass-length ratio is derived directly from the slope
of the plot (Carr and Hermans, 1978; Casassa, 1955). This behavior was
observed at low fibrinogen concentrations and in the presence of Cl (see
Results). When the diameter grows relative to , the plot is no longer
linear, but the quantity c13, where c is the fibrinogen concentration,
changes linearly with 2, and the intercept of the plot gives the mass-
length ratio of the fibers (Carr and Hermans, 1978). This behavior was
observed at high fibrinogen concentrations and in the presence of F.
Clots were prepared for scanning electron microscope experiments by
fixation, dehydration, critical point drying, and sputter coating with gold as
described previously (Langer et al., 1988; Weisel, 1992). The clots were
formed by addition of thrombin to 3 M fibrinogen to give a final
concentration of 1 nM under the different conditions described in the
Results. Clotting was allowed to proceed for 1.5–2 h at room temperature.
Specimens were observed and photographed using a Philips XL20 scan-
ning electron microscope.
RESULTS
Fig. 1 reports the asymptotic values of turbidity of clots
grown as a function of the concentration of different anions,
with the ionic strength kept constant with NaF. No change
is observed in the presence of acetate or cacodylate, thereby
proving that F behaves as a good inert anion because its
properties are identical to those of bulky anions. The inert
behavior of F is to be expected from consideration of its
hydration properties (Collins, 1995, 1997), and the data in
Fig. 1 support conclusions drawn in previous studies using
this anion (Ayala and Di Cera, 1994). Results similar to
those seen for cacodylate and acetate are obtained with
organic phosphates such as 2,3-diphosphoglycerate and ino-
sitol hexaphosphate (data not shown). On the other hand, an
almost complete inhibition of lateral aggregation of fibrin is
found in the presence of Cl or Br around the concentra-
tion of 200 mM. An even larger effect is seen in the
presence of I or ClO4
, which inhibit lateral aggregation
around 100 mM. The observed salt-specific effect is also
observed under physiological conditions of pH and temper-
ature. These measurements prove unequivocally that the
concentration of the physiological anion Cl plays a key
role in determining the thickness of fibrin fibers.
This conclusion is directly supported by scanning elec-
tron microscopy of clots made in the presence of Cl or F.
Direct visualization of the clots is important to verify the
assumptions relating turbidity to fiber diameter and to gain
more detailed structural information on clot structure. These
experiments were done at fibrinogen concentrations (gen-
erally, 3 M) higher than those of the turbidity measure-
ments just described to obtain clots that were stable enough
to withstand the preparation for microscopy and to mimic
more closely physiological concentrations (7 M). We
found that, at these concentrations, fibrinogen is not soluble
FIGURE 1 Turbidity of fibrin clots developed in the presence of differ-
ent salts, at I  200 mM kept constant with NaF. Experimental conditions
are as follows: 4 nM thrombin, 0.25 M fibrinogen, 5 mM Tris, 0.1% PEG,
1 mM EDTA, pH 8.0 at 25°C. Salts are as follows: E, sodium cacodylate;
F, CH3COONa; , NaBr; f, NaCl; ‚, NaI; Œ, NaClO4.
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in NaF buffers, so all experiments were done with 0.05 M
NaCl in the buffers. For example, clots were made at 0.05,
0.10, 0.15, 0.20, 0.30, 0.40, and 0.50 M NaCl and at the
same NaF concentrations all containing 0.05 M NaCl. Thus,
comparisons could be made of clots either with the same
concentration of different anions or with the different ions
but the same total ionic strength. Clots were made at pH 6.5,
7.5, 8.0, and 9.5. Interestingly, clots made in the presence of
NaF were uniformly more stable mechanically than those
made in NaCl, which had a greater tendency to collapse
during preparation for microscopy. These properties of fi-
brinogen in NaF buffers may also be relevant to the prep-
aration of crystals for x-ray diffraction analysis.
Some examples of electron micrographs from these ex-
periments are shown in Fig. 2. As indicated by the turbidity
measurements, the fibers formed in NaF are thicker than
those formed in NaCl. The mean diameter of fiber bundles
is 148  81 nm for clots made in NaF as compared with
60  22 nm for clots formed in NaCl. The pores in the NaF
clots are considerably larger than those in NaCl clots. Es-
timates of fiber densities, calculated from counts of number
of fibers in random directions across the images, are 47
fibers bundles per 106 nm3 for NaF clots versus 116 fiber
bundles per 106 nm3 for NaCl clots. Fibers in NaF clots are
generally more straight or gently curved, whereas those in
NaCl clots often display sharp bends or turns. The differ-
ences in fiber structure gives clots formed in NaCl more
irregularity in the overall appearance of their pore structure.
It has long been known that fibrin clots formed at high pH
have low turbidity. This notion was fostered by pioneering
studies carried out in the presence of Cl concentrations of
100–500 mM (Ferry and Morrison, 1947). In the presence
of 200 mM Cl, an increase in pH brings about a decrease
in turbidity (Fig. 3). However, in the presence of 200 mM
F, the turbidity remains significant at high pH and actually
exceeds that of fibers grown at low pH in the presence of
Cl or F. This result is reinforced by electron microscopy
images shown in Fig. 4. At pH 9.5, the differences between
the appearance of clots formed in NaF and NaCl are even
more striking than at lower pH. The clots formed in NaF are
made up of very thick fiber bundles, and fibers associate
laterally to form very complex aggregates. Clots formed in
NaCl at pH 9.5 are made up of very thin fibers, with a much
larger number of branch points, so that the pore size is very
small. The pore sizes are usually relatively uniform in these
FIGURE 2 Scanning electron micrographs of fibrin clots grown in the
presence of NaCl or NaF. Experimental conditions are as follows: 4 nM
thrombin, 3 M fibrinogen, 50 mM Tris, pH 7.5 at 22°C, plus the
following salts: (A) 150 mM NaF, 50 mM NaCl; (B) 200 mM NaCl. Bar,
5 m.
FIGURE 3 Turbidity of fibrin clots developed in the presence of 200
mM NaCl (E) or NaF (F) as a function of pH. Experimental conditions are
as follows: 4 nM thrombin, 0.25 M fibrinogen, 10 mM CHES, 5 mM Tris,
5 mM bisTris, 0.1% PEG, 1 mM EDTA at 25°C. The pH dependence of the
turbidity was analyzed according to the empirical expression   0[1 
([H]/K1)  (K2/[H])], where 0 is the pH-independent value of  and K1
and K2 are the dissociation constants of two ionizable groups. The equation
assumes that the turbidity is directly proportional to the formation of lateral
aggregates that is promoted by protonation of one group in the acidic pH
range and deprotonation a second group in the basic pH range. The best-fit
parameter values for the data are s follows: for NaF, 0  0.116  0.002,
pK1 6.16 0.04, and pK2 9.18 0.03; for NaCl, 0 0.015 0.002,
pK1  7.27  0.09, and pK2  10.
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clots. The mean diameter of fiber bundles at pH 9.5 is
164  75 nm for clots made in NaF as compared with 55
12 nm for clots formed in NaCl. Estimates of fiber densities
are 40 fiber bundles per 106 nm3 for NaF clots and 182 fiber
bundles per 106 nm3 for NaCl clots.
The pH dependence of the turbidity in the presence of F
is reminiscent of the pH dependence of Km for an enzyme-
substrate interaction in which two ionizable groups control
optimal binding, with one group being protonated and the
other being deprotonated. By analogy, an empirical expres-
sion can be derived for the analysis of the data in Fig. 3 that
expresses the pH dependence of the turbidity in terms of
two ionizable groups. One such group has pKa  6.2 and
must be protonated for optimal aggregation, whereas the
other group has pKa  9.2 and must be deprotonated. Cl

increases the pKa of both groups, but its effect is predom-
inant on the second group, which increases its pKa well
beyond 10 in the presence of the anion, thereby opposing
deprotonation and lateral aggregation of fibrin fibers.
Elucidation of the role of Cl also helps us understand
the function of the release of fibrinopeptide B in the poly-
merization of fibrin fibers. Fig. 5 shows the mass-length
ratio of fibrin fibers grown from digestion of fibrinogen
with thrombin or ancrod. The mass-length ratio of fibers
produced without the release of fibrinopeptide B is lower
than that of fibers grown when both fibrinopeptides A and
B are released. This result suggests a connection between
fibrinopeptide B cleavage and lateral aggregation, although
other results indicate that the sites exposed by fibrinopep-
tide B release mainly reinforce linear polymerization
(Blomback et al., 1978; Hantgan and Hermans, 1979; Lau-
dano and Doolittle, 1980; Hantgan et al., 1983; Shainoff and
Dardik, 1983; Veklich et al., 1993; Weisel et al., 1993;
Gorkun et al., 1994). However, when the same experiments
are carried out in the absence of Cl and in the presence of
F, the effect of fibrinopeptide B release is reversed. Fibers
grown in ancrod are thicker than those grown in the pres-
ence of thrombin. This means that fibrinopeptide B release
plays no direct role in lateral aggregation. The effect be-
comes even more appreciable when the fibrinogen concen-
tration increases and reaches its physiological range,
thereby demonstrating the importance of this mechanism for
fibrin polymerization in vivo.
DISCUSSION
Individual ions may be systematically classified as chao-
tropes or kosmotropes by the sign of the Jones-Dole vis-
cosity B coefficient (Jones and Dole, 1929) that correlates
with charge density and the strength of interaction with
water molecules (Collins, 1997). The effect of different
FIGURE 4 Scanning electron micrographs of fibrin clots grown in the
presence of NaCl or NaF. Experimental conditions are as follows: 4 nM
thrombin, 3 M fibrinogen, 10 mM CHES, 5 mM Tris, 5 mM bisTris, pH
9.5 at 22°C, plus the following salts: (A) 150 mM NaF, 50 mM NaCl; (B)
200 mM NaCl. Bar, 5 m.
FIGURE 5 Mass-length ratio  of fibrin fibers as a function of the
fibrinogen concentration. Data were derived from the wavelength depen-
dence of the turbidity of fibrin clots according to the theory of light
scattering of rod-like particles (Casassa, 1955). Experimental conditions
are as follows: 4 nM thrombin (F, f) or ancrod (E, ), 5 mM Tris, 0.1%
PEG, 1 mM EDTA, pH 8.0 at 25°C, in the presence of 200 mM NaCl
(, f) or NaF (E, F).
1976 Biophysical Journal Volume 75 October 1998
anions on fibrin polymerization is consistent with a binding
interaction the strength of which follows the properties of
the anion in the Jones-Dole scale. Kosmotrope anions, such
as F, cacodylate, acetate, and organic phosphates, bind
water molecules tightly, taking up a greater size of their
anhydrous volume. This property makes them little reactive
with proteins. On the other hand, chaotrope ions, such as
Cl and ClO4
, bind water molecules weakly, allowing an
easy removal of them from the complex with a limited steric
impairment. Among the anions of physiological relevance,
Cl is the only chaotrope and tends to interact with basic
groups of proteins with significant affinity. The effects
reported in this study on fibrin polymerization reflect this
tendency of Cl to interact with protein moieties.
Fibrin monomers polymerize via complementary binding
sites to form two-stranded protofibrils. The structure of
some of the complementary polymerization sites of fibrin
has been determined recently (Spraggon et al., 1997; Yee et
al., 1997). Protofibrils can be formed after the release of
either fibrinopeptide A or B (Hantgan and Hermans, 1979;
Shainoff and Dardik, 1983; Weisel, 1986), whereas the
sequential release of A and then B fibrinopeptides signifi-
cantly enhances lateral aggregation by allowing intermolec-
ular interactions of the carboxyl-terminal  chains (Veklich
et al., 1993; Gorkun et al., 1994). Cl exerts its physiolog-
ical role by impairing lateral aggregation of protofibrils and
maintains a smaller size of the fibers. The influence of pH
on these effects may be related to the ionization and calo-
rimetric changes that occur on polymerization (Mihalyi,
1954a,b; Sturtevant et al., 1955). Lateral aggregation of
fibrin fibers is promoted by two ionizable groups. One
group with pKa 6.2 must be protonated and the other with
pKa  9.2 must be deprotonated for optimal aggregation.
We can only speculate on the nature of these groups from
their pKa values. The pKa of 6.2 is most likely due to a
histidine residue. A comparison of the amino-terminal se-
quence of the  chain of fibrinogen from different species
show His16 as a highly conserved residue (Laudano and
Doolittle, 1980; Doolittle, 1983). A critical role for this
residue in end-to-end polymerization was proposed by
Shimizu et al. (1983, 1986) from affinity chromatography
experiments on fibrinogen fragments. The exposure of the
Gly15-His16-Arg17 sequence after the release of fibrino-
peptide B is essential for the formation of central polymer-
ization sites that interact with sites at the end of the mole-
cule (Shainoff and Dardik, 1983; Medved et al., 1993).
Laudano and Doolittle (1980) reported the presence of
specific sites on the fibrinogen molecule for the Gly-His-
Arg-Pro peptide and emphasized the importance of His in
the sequence. Quite likely, His16 of the  chain of fibrin-
ogen plays a key role in lateral aggregation and must be
protonated for optimal coupling with a negatively charged
moiety on the complementary site. In the presence of Cl,
the pKa of this histidine is increased and aggregation is
similarly enhanced at low pH in NaCl or NaF. The other
Cl-linked ionizable group with pKa 9.2 may be a lysine,
tyrosine, arginine, or the amino terminus of any of the
chains. The lateral aggregation of fibrin increases with the
group in the deprotonated state, whereas Cl tends to in-
crease the pKa, promote protonation, and oppose lateral
aggregation.
Although identification of the ionizable groups remains
elusive, specific domains of the fibrin monomer can be
targeted with anionic ligands to mimic the physiological
effect of Cl. This information can be exploited to search
for ligands that specifically inhibit fibrin polymerization by
binding to the domain responsible for Cl binding. The
feasibility of this approach is demonstrated already by the
drastic effect on fibrin polymerization observed in the pres-
ence of I or ClO4
, two strongly chaotropic anions that
interact with fibrin more strongly than the physiological
anion Cl. Aggregation is severely reduced in the presence
of these anions. Phosphate and carbonate, other physiolog-
ically important anions, are kosmotropic and have little
effect on fibrin polymerization.
Our results on the role of Cl also provide new insights
into the role of fibrinopeptide B release in fibrin polymer-
ization, which has so far been controversial. Fibrinopeptide
B cleavage exposes an aggregation site independent of that
uncovered by fibrinopeptide A release (Shainoff and
Dardik, 1979). Blomback et al. (1978) proposed that the
release of fibrinopeptide A controls the end-to-end poly-
merization, whereas cleavage of fibrinopeptide B promotes
lateral aggregation of protofibrils and formation of fibrin
fibers. Dyr et al. (1989) suggested an enhancement for
polymerization sites unmasked by fibrinopeptide A release
due to release of fibrinopeptide B. However, Laudano and
Doolittle (1980) found no inhibition of aggregation of fibrin
by tetrapeptide analogs to the amino-terminal sequence of
the  chain exposed after the release of fibrinopeptide B.
Furthermore, structural studies showed that release of either
fibrinopeptide triggers similar modes of aggregation
(Weisel, 1986; Mosesson et al., 1987). These controversial
findings can be partially reconciled by recent findings on
the role of the carboxyl-terminal  chains in lateral aggre-
gation (Veklich et al., 1993; Gorkun et al., 1994), but it is
also necessary to consider the differences in experimental
conditions used and the previously unrecognized role of Cl
in fibrin polymerization.
The role of fibrinopeptide B in determining the clot
structure depends on the particular anion present in solution
and the Cl concentration. In the presence of Cl, the
release of fibrinopeptide B tends to increase the mass-length
ratio of fibrin fibers, especially at high fibrinogen concen-
trations. In the absence of Cl, or in the presence of F, the
effect of fibrinopeptide B cleavage is actually reversed, such
that fibrin fibers grow thicker when only fibrinopeptide A is
released, demonstrating that there is no direct relationship
between fibrinopeptide B cleavage and lateral aggregation.
In view of the effect of Cl and fibrinogen concentration, as
well as Ca2 and other factors, on the size of the fibrin
fibers (see Fig. 5), it is not difficult to envision large
discrepancies in experimental data collected on clot struc-
tures under conditions in which the NaCl or fibrinogen
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concentrations are not strictly comparable. In previous stud-
ies, the fibrinogen concentration varied significantly, being
very low for light-scattering studies and very high for elec-
tron microscopy analysis, as did the Cl concentration,
which ranged from 50 to 500 mM. Small changes in NaCl
concentration may yield opposite effects on the release of
fibrinopeptide B, whereas experiments carried out at high
fibrinogen concentrations will tend to exacerbate the effect
of Cl.
In the absence of Cl, thick fibers are formed, but Cl
inhibits lateral aggregation. Under physiological conditions
in the presence of Cl, fiber thickness can be regulated by
fibrinopeptide B cleavage, which leads to release of the C
domains to promote lateral aggregation (Gorkun et al.,
1994). Thus, Cl allows the production of fibers of appro-
priate thickness for different conditions to guarantee the
optimal mechanical properties of the fibrin scaffold.
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